MEDRx
Kagawa, Yamaguchi, Japan
About MEDRx
MedRx is a pharmaceutical company that develops pharmaceutical drugs based on the transdermal absorption system in Japan. It develops medicines based on Ionic Liquid Transdermal System. The company’s products in the pipeline include MRX-4TZT; MRX-5LBT; MRX-10XT; and MRX-5DML. It also offers microneedle patch for delivery of vaccines and/or APIs through the skin. MedRx Co., Ltd. was founded in 2002 and is headquartered in Higashikagawa, Japan.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.1M
- Funding stage: IPO
- Last round: Post-IPO Debt (Jun 2016)
- Ticker: tyo:4586
- Website: medrx.co.jp
- Phone: +81 0879-23-3071
Industries & Categories
Biotechnology, Health Care, Hospital, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/medrx-2253542 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.